Problem: Multiple Sclerosis: In a 2018 article published in The Lancet, Kappos et al. studied the effects of the drug Siponimod in treating patients with secondary progressive multiple sclerosis (SPMS) using a double-blind, randomized, controlled study. Of the 1099 patients given the drug, 198 experienced a severe adverse outcome. Of the 546 patients given the placebo, 82 experienced a severe adverse outcome a) Find the percentage in each group that suffered a severe adverse outcome. Siponimod group: % Placebo group: % (round both to the nearest tenth) a) Use these results to fill in the following two-way table with the counts in each category. Severe Adverse Outcome Drug Placebo Yes No. Need Assignment Help?